Persistent abnormalities in Rolandic thalamocortical white matter circuits in childhood epilepsy with centrotemporal spikes.


Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
11 2020
Historique:
received: 24 05 2020
revised: 01 08 2020
accepted: 12 08 2020
pubmed: 19 9 2020
medline: 4 2 2021
entrez: 18 9 2020
Statut: ppublish

Résumé

Childhood epilepsy with centrotemporal spikes (CECTS) is a common, focal, transient, developmental epilepsy syndrome characterized by unilateral or bilateral, independent epileptiform spikes in the Rolandic regions of unknown etiology. Given that CECTS presents during a period of dramatic white matter maturation and thatspikes in CECTS are activated during non-rapid eye movement (REM) sleep, we hypothesized that children with CECTS would have aberrant development of white matter connectivity between the thalamus and the Rolandic cortex. We further tested whether Rolandic thalamocortical structural connectivity correlates with spike rate during non-REM sleep. Twenty-three children with CECTS (age = 8-15 years) and 19 controls (age = 7-15 years) underwent 3-T structural and diffusion-weighted magnetic resonance imaging and 72-electrode electroencephalographic recordings. Thalamocortical structural connectivity to Rolandic and non-Rolandic cortices was quantified using probabilistic tractography. Developmental changes in connectivity were compared between groups using bootstrap analyses. Longitudinal analysis was performed in four subjects with 1-year follow-up data. Spike rate was quantified during non-REM sleep using manual and automated techniques and compared to Rolandic connectivity using regression analyses. Children with CECTS had aberrant development of thalamocortical connectivity to the Rolandic cortex compared to controls (P = .01), where the expected increase in connectivity with age was not observed in CECTS. There was no difference in the development of thalamocortical connectivity to non-Rolandic regions between CECTS subjects and controls (P = .19). Subjects with CECTS observed longitudinally had reductions in thalamocortical connectivity to the Rolandic cortex over time. No definite relationship was found between Rolandic connectivity and non-REM spike rate (P > .05). These data provide evidence that abnormal maturation of thalamocortical white matter circuits to the Rolandic cortex is a feature of CECTS. Our data further suggest that the abnormalities in these tracts do not recover, but are increasingly dysmature over time, implicating a permanent but potentially compensatory process contributing to disease resolution.

Identifiants

pubmed: 32944938
doi: 10.1111/epi.16681
pmc: PMC7722074
mid: NIHMS1650461
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2500-2508

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS102190
Pays : United States
Organisme : NINDS NIH HHS
ID : K23 NS092923
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS115868
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS107291
Pays : United States

Informations de copyright

© 2020 International League Against Epilepsy.

Références

Epilepsy Res. 2017 Feb;130:74-80
pubmed: 28160673
Brain Dev. 2018 Mar;40(3):205-210
pubmed: 29056244
Epilepsia. 2016 May;57(5):805-11
pubmed: 27012680
Am J Psychiatry. 2007 Mar;164(3):483-92
pubmed: 17329474
Nat Genet. 2013 Sep;45(9):1067-72
pubmed: 23933819
AJNR Am J Neuroradiol. 2009 Oct;30(9):1780-6
pubmed: 19574497
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Science. 1993 Oct 29;262(5134):679-85
pubmed: 8235588
Seizure. 2010 Oct;19(8):501-6
pubmed: 20688544
Eur J Paediatr Neurol. 2006 May;10(3):107-13
pubmed: 16638642
Epilepsy Behav. 2015 Apr;45:85-91
pubmed: 25775975
Trends Cogn Sci. 2005 Feb;9(2):60-8
pubmed: 15668098
Clin Neurophysiol. 2017 Jan;128(1):243-250
pubmed: 27913148
Ann Neurol. 2004 Jul;56(1):129-32
pubmed: 15236411
Epilepsy Res Treat. 2013;2013:583531
pubmed: 23991336
Eur J Hum Genet. 2009 Sep;17(9):1171-81
pubmed: 19172991
J Clin Sleep Med. 2007 Mar 15;3(2):121-31
pubmed: 17557422
J Clin Neurophysiol. 2018 Sep;35(5):370-374
pubmed: 29933261
Epilepsia. 2015 Jan;56(1):40-8
pubmed: 25431231
J Neurosci. 2011 Dec 7;31(49):17821-34
pubmed: 22159098
Ann Neurol. 1995 Feb;37(2):146-57
pubmed: 7847856
Epilepsia. 2017 Oct;58(10):1673-1685
pubmed: 28801973
Am J Psychiatry. 2010 Nov;167(11):1339-48
pubmed: 20843876
Prog Neurobiol. 2005 Feb;75(2):125-41
pubmed: 15784303
Nat Neurosci. 1999 Oct;2(10):861-3
pubmed: 10491603
Neurology. 2009 Sep 15;73(11):843-6
pubmed: 19752450
JAMA Neurol. 2020 Jan 1;77(1):49-57
pubmed: 31633742
JAMA Neurol. 2020 Jan 1;77(1):103-108
pubmed: 31633740
Epilepsia. 2006 Mar;47(3):550-5
pubmed: 16529620
Epilepsia. 1998 Aug;39(8):884-6
pubmed: 9701381
Epilepsia Open. 2018 Jul 22;3(3):409-417
pubmed: 30187012
Magn Reson Med. 2003 Nov;50(5):1077-88
pubmed: 14587019
Clin Neurophysiol. 2017 Oct;128(10):1994-2005
pubmed: 28837905
Epilepsia. 2013 Apr;54(4):733-40
pubmed: 23506484
Epilepsy Behav. 2020 Feb;103(Pt A):106437
pubmed: 31645314
Nat Neurosci. 2011 Aug 21;14(9):1167-73
pubmed: 21857658
Neurology. 2014 Apr 1;82(13):1162-6
pubmed: 24562059
Epilepsia. 2010 Apr;51(4):676-85
pubmed: 20196795
Brain Commun. 2019;1(1):fcz002
pubmed: 31608323
Neuroimage. 2009 Mar;45(1 Suppl):S173-86
pubmed: 19059349
Epilepsy Behav. 2018 Jan;78:243-255
pubmed: 29133062
Neurology. 1997 Feb;48(2):430-7
pubmed: 9040734
J Clin Neurophysiol. 2018 Sep;35(5):375-380
pubmed: 30028830
Brain. 2008 Sep;131(Pt 9):2264-86
pubmed: 18718967
Hum Brain Mapp. 2018 Jan;39(1):204-217
pubmed: 29030921
Neurology. 2012 May 29;78(22):1721-7
pubmed: 22539569
Epilepsia. 2014 Apr;55(4):475-82
pubmed: 24730690
Prog Brain Res. 2014;213:223-52
pubmed: 25194492
Neuroimage. 2015 Mar;108:23-33
pubmed: 25534110

Auteurs

Emily L Thorn (EL)

Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Elson S. Floyd College of Medicine, Washington State University, Spokane, Washington, USA.

Lauren M Ostrowski (LM)

Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Dhinakaran M Chinappen (DM)

Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Jin Jing (J)

Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.

M Brandon Westover (MB)

Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.

Steven M Stufflebeam (SM)

Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, Massachusetts, USA.

Mark A Kramer (MA)

Department of Mathematics and Statistics, Boston University, Boston, Massachusetts, USA.

Catherine J Chu (CJ)

Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH